Abstract
Women are an increasing proportion of the HIV-infected population. In addition, compared with their HIV-negative counterparts, they have a greater incidence of both cervical intraepithelial neoplasia (CIN) and invasive cervical cancer, which tends to be more progressive and aggressive. The development of invasive cervical carcinoma in an HIV-infected woman is an AIDS-defining diagnosis. However, what is not clear is whether women who are identified with cervical carcinoma should be offered screening for HIV infection. This review addresses these issues and provides a cost-effectiveness assessment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
